Ionis Pharmaceuticals: Oppenheimer cuts target price to $70 from $85
IONS•Oppenheimer cut its target price for Ionis Pharmaceuticals to $70 from $85.
Related News
Goldman Sachs raises total voting rights in ThyssenKrupp to 5.04% from 4.98%
GS•
NewLake Capital CEO joins lending panel at IgniteIt Cannabis Capital and Policy Summit
NLCP•
Sterling nudges lower as Waller comments, US data underpin dollar
TLT•
Abbott wins FDA approval for UltiSynq defibrillation lead
ABT•
Oil falls as Trump downplays prospect of escalation with Iran
USO•